Investors & Media
Ionis is focused on delivering RNA-targeted therapeutics with transformational potential. Our antisense oligonucleotide drug discovery platform has transformed the lives of patients with devastating diseases, including SMA, hATTR, and FCS. We have the potential to treat many additional diseases where other therapeutic approaches have proven ineffective or do not exist.
Data Provided by Refinitiv. Minimum 15 minutes delayed.